Abstract
We investigated early postoperative morbidity, mortality, and long-term outcomes in patients with liver cirrhosis (LC) who had undergone curative surgery for gastric cancer. The medical records of patients with LC who had undergone radical gastrectomy for gastric adenocarcinoma between January 1996 and September 2006 were retrospectively reviewed. A total of 57 patients were enrolled in this study. Forty-six patients (81%) were classified into Child’s class A. In 22 patients (39%) postoperative complications developed, the most common being ascites (23%), followed by wound infection and hepatic encephalopathy. Postoperative ascites occurred more frequently in patients with Child’s class B or C than in those with class A (63.6% vs 13%, P = 0.001). Massive ascites developed in 4 patients, 3 of whom had Child’s class B and underwent D2 lymph node (LN) dissection, and 1 of whom had Child’s class C and a D1 LN dissection. Postoperative mortality occurred in 5 patients (9%), with a significantly higher mortality rate for patients with Child’s class B or C than for those with class A (27.2% vs 4.3%, P = 0.045). With a median follow-up of 32 months, the estimated 5-year survival rate for all patients was 54%. Regardless of the tumor depth, overall survival was longer for patients with Child’s class A than for those with Child’s class B or C. These results demonstrated that radical gastrectomy with extended LN dissection is feasible in patients with compensated LC. For patients with moderate to severe hepatic dysfunction, however, D1 or less extensive LN dissection may be the more reasonable surgical procedure.
Similar content being viewed by others
References
Shin HR, Ahn YO, Bae JM, Shin MH, Lee DH, Lee CW, Ohrr HC, Ahn DH, Ferlay J, Parkin DM, Oh DK, Park JG (2002) Cancer incidence in Korea. Cancer Res Treatment 34:405–408
Lee JH, Kim J, Cheong JH, Hyung WJ, Choi SH, Noh SH (2005) Gastric cancer surgery in cirrhotic patients: result of gastrectomy with D2 lymph node dissection. World J Gastroenterol 11:4623–4627
Yoo CH, Noh SH, Shin DW, Choi SH, Min JS (2000) Recurrence following curative resection for gastric carcinoma. Br J Surg 87:236–242
Floreani A, Biagini MR, Chiaramonte M, Milani S, Surrenti C, Naccarato R (1993) Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC). Ital J Gastroenterol 25:473–476
Zullo A, Romiti A, Tomao S, Hassan C, Rinaldi V, Giustini M, Morini S, Taggi F (2003) Gastric cancer prevalence in patients with liver cirrhosis. Eur J Cancer Prev 12:179–182
Liu CL, Fan ST, Lo CM, Wong Y, Ng IO, Lam CM, Poon RT, Wong J (2004) Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg 239:194–201
Mansour A, Watson W, Shayani V, Pickleman J (1997) Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery 122:730–735
Isozaki H, Okajima K, Ichinona T, Fujii K, Nomura E, Izumi N (1997) Surgery for gastric cancer in patients with liver cirrhosis. Surg Today 27:17–21
Ryu KW, Lee JH, Kim YW, Park JW, Bae JM (2005) Management of ascites after radical surgery in gastric cancer patients with liver cirrhosis and minimal hepatic dysfunction. World J Surg 29:653–656
Dumont AE, Mulholland JH (1962) Alteration in thoracic duct lymph flow in hepatic cirrhosis. Significance in portal hypertension. Ann Surg 156:668–677
Kumagai K (1998) Intractable ascites following surgery for gastric carcinoma. Surg 15:236–240
Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ (1993) Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 80:1015–1018
Takeda J, Hashimoto K, Tanaka T, Koufuji K, Kakegawa T (1992) Review of operative indication and prognosis in gastric cancer with hepatic cirrhosis. Hepatogastroenterology 39:433–436
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jang, H.J., Kim, J.H., Song, H.H. et al. Clinical Outcomes of Patients with Liver Cirrhosis Who Underwent Curative Surgery for Gastric Cancer: A Retrospective Multi-center Study. Dig Dis Sci 53, 399–404 (2008). https://doi.org/10.1007/s10620-007-9884-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-007-9884-3